This cohort study of data from the National Cancer Database on patients with pancreatic adenocarcinoma who received neoadjuvant chemotherapy compares overall survival between those who received adjuvant chemotherapy and those who did not.
Referenced link: https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html
Originally posted by Phys.org / @[email protected]: https://twitter.com/medical_xpress/status/1600894237909958656#m
RT by @physorg_com: Largest study of its kind reveals #adjuvantchemotherapy improves overall survival for #pancreaticcancer patients @CUAnschutz @JAMAOnc https://jamanetwork.com/journals/jamaoncology/fullarticle/2799187 https://medicalxpress.com/news/2022-12-largest-kind-reveals-adjuvant-chemotherapy.html
Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.